middle.news
Pacific Edge Battles Medicare Non-Coverage for Cxbladder Amid Legal and Clinical Pushback
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Pacific Edge Battles Medicare Non-Coverage for Cxbladder Amid Legal and Clinical Pushback
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Novitas finalizes non-coverage determination for Cxbladder tests effective February 23, 2025
Pacific Edge disputes Novitas' clinical evidence assessment and plans legal and reconsideration actions
Medicare and Medicare Advantage accounted for 54% of US commercial tests and 59% of total revenue in H1 2025
Company has $28.5 million in reserves and is restructuring to reduce cash burn
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pacific Edge (ASX:PEB)
OPEN ARTICLE